Conditions: Relapsed/Refractory Hematological Malignancies; Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL; Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation); Relapsed/Refractory Mantle Cell Lymphoma (MCL); Relapsed/Refractory Waldenström Macroglobulinemia (WM); Relapsed/Refractory Marginal Zone Lymphoma (MZL); Relapsed/Refractory Follicular Lymphoma (FL)
Interventions: Drug: APG-3288
Sponsors: Ascentage Pharma Group Inc.
Not yet recruiting Conditions: Relapsed/Refractory Hematological Malignancies; Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL; Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation); Relapsed/Refractory Mantle Cell Lymphoma (MCL); Relapsed/Refractory Waldenström Macroglobulinemia (WM); Relapsed/Refractory Marginal Zone Lymphoma (MZL); Relapsed/Refractory Follicular Lymphoma (FL)
Interventions: Drug: APG-3288
Sponsors: Ascentage Pharma Group Inc.
Not yet recruiting
